| Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications D Mathew, JR Giles, AE Baxter, DA Oldridge, AR Greenplate, JE Wu, ... Science 369 (6508), eabc8511, 2020 | 1570 | 2020 |
| Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy E Sotillo, DM Barrett, KL Black, A Bagashev, D Oldridge, G Wu, ... Cancer discovery 5 (12), 1282-1295, 2015 | 1214 | 2015 |
| mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern RR Goel, MM Painter, SA Apostolidis, D Mathew, W Meng, AM Rosenfeld, ... Science 374 (6572), abm0829, 2021 | 732 | 2021 |
| Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination RR Goel, SA Apostolidis, MM Painter, D Mathew, A Pattekar, O Kuthuru, ... Science immunology 6 (58), eabi6950, 2021 | 646 | 2021 |
| Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ... Nature genetics 47 (8), 864-871, 2015 | 554 | 2015 |
| CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer EM Bange, NA Han, P Wileyto, JY Kim, S Gouma, J Robinson, ... Nature medicine 27 (7), 1280-1289, 2021 | 428 | 2021 |
| Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection EM Anderson, EC Goodwin, A Verma, CP Arevalo, MJ Bolton, ME Weirick, ... Cell 184 (7), 1858-1864. e10, 2021 | 396 | 2021 |
| Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination MM Painter, D Mathew, RR Goel, SA Apostolidis, A Pattekar, O Kuthuru, ... Immunity 54 (9), 2133-2142. e3, 2021 | 379 | 2021 |
| MRI features predict survival and molecular markers in diffuse lower-grade gliomas H Zhou, M Vallières, HX Bai, C Su, H Tang, D Oldridge, Z Zhang, B Xiao, ... Neuro-oncology 19 (6), 862-870, 2017 | 344 | 2017 |
| Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism DA Oldridge, AC Wood, N Weichert-Leahey, I Crimmins, R Sussman, ... Nature 528 (7582), 418-421, 2015 | 305 | 2015 |
| Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19 LA Vella, JR Giles, AE Baxter, DA Oldridge, C Diorio, L Kuri-Cervantes, ... Science immunology 6 (57), eabf7570, 2021 | 200 | 2021 |
| CODEX: a normalization and copy number variation detection method for whole exome sequencing Y Jiang, DA Oldridge, SJ Diskin, NR Zhang Nucleic acids research 43 (6), e39-e39, 2015 | 169 | 2015 |
| CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy V Pillai, K Muralidharan, W Meng, A Bagashev, DA Oldridge, J Rosenthal, ... Blood advances 3 (22), 3539-3549, 2019 | 168 | 2019 |
| Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine RR Goel, MM Painter, KA Lundgreen, SA Apostolidis, AE Baxter, JR Giles, ... Cell 185 (11), 1875-1887. e8, 2022 | 166 | 2022 |
| CASC15-S is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus MR Russell, A Penikis, DA Oldridge, JR Alvarez-Dominguez, L McDaniel, ... Cancer research 75 (15), 3155-3166, 2015 | 158 | 2015 |
| Cross-cohort analysis identifies a TEAD4–MYCN positive feedback loop as the core regulatory element of high-risk neuroblastoma P Rajbhandari, G Lopez, C Capdevila, B Salvatori, J Yu, ... Cancer discovery 8 (5), 582-599, 2018 | 132 | 2018 |
| Rare Variants in TP53 and Susceptibility to Neuroblastoma SJ Diskin, M Capasso, M Diamond, DA Oldridge, K Conkrite, KR Bosse, ... Journal of the National Cancer Institute 106 (4), dju047, 2014 | 125 | 2014 |
| A LIN28B-RAN-AURKA signaling network promotes neuroblastoma tumorigenesis RW Schnepp, P Khurana, EF Attiyeh, P Raman, SE Chodosh, ... Cancer cell 28 (5), 599-609, 2015 | 106 | 2015 |
| UPenn COVID Processing Unit D Mathew, JR Giles, AE Baxter, DA Oldridge, AR Greenplate, JE Wu, ... Deep immune profiling of COVID-19 patients reveals distinct immunotypes with …, 2020 | 98 | 2020 |
| LMO1 synergizes with MYCN to promote neuroblastoma initiation and metastasis S Zhu, X Zhang, N Weichert-Leahey, Z Dong, C Zhang, G Lopez, T Tao, ... Cancer cell 32 (3), 310-323. e5, 2017 | 94 | 2017 |
